Company: LENZ
Filing Date: 2025-04-09
Form Type: 424B3
Source: 0001628280-25-017190
Chunk: 14

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-09
Form: 424B3
Chunk 14
---
 Selling Stockholder           |     | Common Stock Beneficially Owned Prior to Offering |           |     |        |     | Number of Shares of Common Stock Being Offered |           |     |         |     | Common Stock Beneficially Owned After the Offered Shares of Common Stock are Sold |         |     |     |   |
|                                       |     |                                                   |           |     | Number |     |                                                |           |     | Percent |     |                                                                                   |         |     |     |   |
| Ridgeback Capital Investments L.P.(1) |     |                                                   | 1,901,875 |     |        |     |                                                | 1,578,947 |     |         |     |                                                                                   | 322,928 |     | 1.2 | % |

__________________

* Less than 1%

(1) Consists of 1,578,947 shares of common stock purchased in the July 2024 PIPE Financing. Ridgeback Capital Investments LLC, or RCI, is the general partner of Ridgeback Capital Investments L.P., or RCILP. Pursuant to an investment management agreement, Ridgeback Capital Management, LLC, or RCM, maintains investment and voting power with respect to the securities held or controlled by RCI. Wayne Holman, an individual, controls RCM. By reason of the provisions of Rule 13d-3 of the Securities Exchange Act of 1934, as amended, RCM and RCI may be deemed to own beneficially all of the shares owned directly by RCILP. Each of RCM and RCI disclaim beneficial ownership of any of our company’s securities referenced above. The address for RCILP, RCI, RCM and Mr. Holman is 348 W. 14th St., Fl. 4, New York, NY 10014.

<div align='center'>10</div>

### DESCRIPTION OF SECURITIES
The following description of our capital stock and provisions of our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws are summaries and are qualified by reference to our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws and applicable provisions of Delaware corporate law.

#### Authorized Capital Stock
Our authorized capital stock consists of 300,000,000 shares of common stock, par value $0.00001 per share and 10,000,000 shares of preferred stock, par value $0.00001 per share.